Manon Fiorot has been handed a three-month suspension after it was determined she violated the UFC’s anti-doping policy.
Promotion officials announced the news on Thursday.
Fiorot (13-3), 36, was most recently seen losing to former women’s flyweight champion Alexa Grasso in September. Back in May of 2025 at UFC 315 in Montreal, Fiorot dropped a unanimous decision against then-champ Valentina Shevchenko, in Fiorot’s lone UFC title shot to date.
The French fighter’s suspension relates to an in-competition drug test stemming from the Grasso fight, which saw Fiorot test positive for ostarine. Originally developed to help cancer patients rebuild muscle, ostarine is a selective androgen receptor modulator, or SARM. Its use is banned at all times under the UFC’s anti-doping policy, enforced by CSAD (Combat Sports Anti-Doping) with sample collection by Drug Free Sport.
An additional sample provided by Fiorot on October 19 tested negative, following her positive test on September 12, 2026.
During the CSAD investigation into Fiorot’s positive test, her nutritionist was able to provide supplements given to the fighter, which were tested by the Sports Medicine and Research Testing Laboratory (SMRTL), the UFC ADP’s laboratory. Two of the supplements provided tested positive for ostarine.
Given Fiorot’s exposure to the banned substance was not the result of intentional use, she qualified for a reduced suspension. However, as neither supplement was tested or certified, she still bears responsibility, with CSAD implementing a three-month ban.
With Fiorot’s provisional suspension starting on October 19, when she was informed of the failed September test, she will be eligible to return to action on January 19, 2027.
Manon Fiorot does not currently have a fight on the books.

